是否有可能通过拦截CXCR4/CXCL12通路来治疗黑色素瘤?
Miriam Motlak1, Meghna Mathews1, Omar S Al-Odat1
1Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.
Cytokine
|May 5, 2024
概括
CXCR4/CXCL12轴驱动黑色素瘤的进展和转移. 针对这种途径为新的黑色素瘤治疗和改善患者治疗结果提供了潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 黑色素瘤是一种侵袭性皮肤癌,由于转移,其结果不佳.
- CXCR4/CXCL12轴对于黑色素瘤细胞的增殖,入侵,存活和免疫规避至关重要.
- 在瘤微环境中的黑色素瘤细胞相互作用中,CXCR4起着关键作用.
研究的目的:
- 在癌症进展中提供CXCR4/CXCL12轴的概述.
- 阐明CXCR4在黑色素瘤微环境中的作用.
- 研究CXCR4作为预测生物标志物,并讨论CXCR4抑制剂用于黑色素瘤治疗.
主要方法:
- 对黑色素瘤中CXCR4/CXCL12轴的文献综述.
- 分析CXCR4在黑色素瘤转移和瘤微环境中的作用.
- 对CXCR4抑制剂的当前研究和临床试验的审查.
主要成果:
- CXCR4/CXCL12轴对黑色素瘤转移和进展有显著的贡献.
- CXCR4参与黑色素瘤细胞迁移,免疫逃避和与瘤微环境的相互作用.
- CXCR4显示出作为黑色素瘤进展的预测生物标志物的潜力.
结论:
- 准CXCR4/CXCL12轴为黑色素瘤提供了一个有希望的治疗策略.
- 了解CXCR4的作用可以导致新的治疗方法和改善患者的生存率.
- 对CXCR4抑制剂的进一步研究对于克服当前的局限性和提高治疗疗效至关重要.
相关概念视频
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K